RDY · Dr Reddys Laboratories Ltd · Documents

$14.15 +0.40 (+2.91%) At close · Oct 28 Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 28 4.47M Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2025-03-03	2025-02-28
6-K	—	2025-02-25	—
6-K	—	2025-02-14	—
6-K	—	2025-02-12	2025-02-11
6-K	—	2025-02-12	—
6-K	—	2025-02-06	—
6-K	—	2025-02-05	—
6-K	—	2025-02-04	—
6-K	—	2025-02-04	—
6-K	—	2025-02-04	2025-02-03
6-K	—	2025-02-03	2025-02-02
6-K	—	2025-01-29	—
6-K	—	2025-01-29	—
6-K	—	2025-01-24	—
6-K	—	2025-01-24	—
6-K	—	2025-01-24	—
6-K	—	2025-01-24	—
6-K	—	2025-01-23	—
6-K	—	2025-01-23	—
6-K	—	2025-01-22	—
6-K	—	2025-01-10	2025-01-09
6-K	—	2025-01-08	—
6-K	—	2025-01-08	2025-01-07
6-K	—	2024-12-27	—
6-K	—	2024-12-23	—
6-K	—	2024-12-23	—
6-K	—	2024-12-20	—
6-K	—	2024-12-06	—
6-K	—	2024-12-06	2024-12-05
6-K	—	2024-12-03	—
6-K	—	2024-12-02	2024-12-01
6-K	—	2024-11-29	2024-11-28
6-K	—	2024-11-27	—
6-K	—	2024-11-26	—
6-K	—	2024-11-26	—
6-K	—	2024-11-21	2024-11-20
6-K	—	2024-11-20	2024-11-19
6-K	—	2024-11-19	—
6-K	—	2024-11-14	—
6-K	—	2024-11-12	2024-11-11
6-K	—	2024-11-07	2024-11-06
6-K	—	2024-11-06	2024-11-05
6-K	—	2024-11-06	—
6-K	—	2024-11-05	—
6-K	—	2024-11-05	—
6-K	—	2024-11-04	—
6-K	—	2024-10-29	—
6-K	—	2024-10-28	—
6-K	—	2024-10-21	—
6-K	—	2024-10-15	2024-10-14

Showing 201–250 of 745 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 59 filings 54 filers Visit website Investor relations